167.
Lazarus S. Update on Chronic Obstructive Pulmonary Disease / S/ La
zarus // 96th International Conference of the American Thoracic Society, May
2000
.
168.
Lefebvre J. Prospective trial on captopril-relatedcough / J. Lefebvre., L.
Poirier, Y. Lacourciere// Ann. Pharmacother. - 1992. -V. 26 - P. 161-164
169.
Littner M.R. Longacting bronchodilatation with oncedaily dosing ol'ti-
otropiuin (Spiriva) in stable chronic obstructive pulmonary disease / M.R.
Littner, J.S. Ilovite, D.P. Tashkin // Am J Respir Crit Care Med. - 2000. V.
161. P. I 136-1 142.
170.
Long term effects of non-invasive mechanical ventilation on pulmo
nary haemodynamics in patients with chronic respiratory failure / B. Schonho-
fer, T. Barchfeld, M. Wenzel, D. Kohler // Thorax. - 2001. - V. 56. P. 524-
528
171
Maclean AA. Targeting the angiotensin system in posttransplant airway
obliteration: the antifibrotic effect of angiotensin converting enzyme inhibi
tion / A.A. Maclean, M. Liu, S. Fisher// Am J Respir Crit Care Med. - 2000.
V. 162(1). - P. 310-15.
I 72.
Mahler D.A. Efficacy of salmeterol xinafoate in the treatment of COPD
/ D.A. Mahler // Chest. - 1999. - V. I 15. - P. 957-965.
173.
Manchia G. Ambulatory blood pressure is superior to clinic blood pres
sure in predicting treatment-inducedregression of left ventricular hypertrophy
/ G. Manchia, A. Zancetti, E. Agabati-Rosei // Circulation. - 1997. -V. 97. - P
1464-1470.
174.
Marshall R.P. The pulmonary renin-angiotensin system / R.P. Marshall
// Curr
Pharm Des. - 2003. - V. 9(9). - P. 715-22.
175.
Marshall R.P. Angiotensin II and the fibroproliterative response to
acute lung injury / R.P. Marshall, P. Gohlke, R.C. // Chambers Am J Physiol
Lung Cell Mol Physiol. - 2004. - V. 286(1). - P. I 56-64.
